Dr. Gottardi leads the Bioengineering and Biomaterials (Bio2) lab, collaborating on clinical and research efforts to offer engineering solutions for pediatric health, primarily treatments for airway disorders. Dr. Gottardi researches mechanisms of laryngotracheal pathologies, applies tissue engineering to improve pediatric conditions, develops new devices, and formulates controlled drug delivery systems to treat and improve patients’ lives.
Goli Mostoufi-Moab, MD, MSCE, a dual-certified pediatric oncologist and endocrinologist at CHOP, has taken the lead to study endocrinopathies, affecting up to 40 to 60 percent of childhood cancer survivors.
The good news is that more children survive cancer now than ever before, with doctors able to cure nearly 80 percent of patients. But that doesn't mean that kids who survive cancer stop fighting once their treatment ends, because many face a variety of physical and emotional challenges as a result of their treatment.
Monrovia, Calif.-based St. Baldrick's Foundation recently announced $699,186 in grants to one consortium and three cancer researchers at The Children's Hospital of Philadelphia. The Testicular Cryopreservation Consortium will receive $125,000, while Children's Hospital investigators Shannon Maude, MD, PhD, Michael Hogarty, MD, and Vandana Batra, MD, will receive $330,000, $110,000, and $134,186, respectively.
The Goldmuntz Laboratory manages a cardiac biorepository of case and parental samples, all of which have congenital heart disease. The lab has previously performed work assessing the functional significance of case variants in cardiac-related genes, and many of the samples managed by the lab have been array-genotyped for genome-wide association studies.